دورية أكاديمية
أعرض في EDS

Effects of boosting and waning in highly exposed populations on dengue epidemic dynamics.

التفاصيل البيبلوغرافية
العنوان: Effects of boosting and waning in highly exposed populations on dengue epidemic dynamics.
المؤلفون: Aogo RA; Viral Epidemiology and Immunity Unit, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892-3203, USA., Zambrana JV; Sustainable Sciences Institute, Managua 14007, Nicaragua.; Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI 48109-2029, USA., Sanchez N; Sustainable Sciences Institute, Managua 14007, Nicaragua., Ojeda S; Sustainable Sciences Institute, Managua 14007, Nicaragua., Kuan G; Sustainable Sciences Institute, Managua 14007, Nicaragua.; Centro de Salud Sócrates Flores Vivas, Ministry of Health, Managua 12014, Nicaragua., Balmaseda A; Sustainable Sciences Institute, Managua 14007, Nicaragua.; Laboratorio Nacional de Virología, Centro Nacional de Diagnóstico y Referencia, Ministry of Health, Managua 16064, Nicaragua., Gordon A; Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI 48109-2029, USA., Harris E; Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA 94720-3370, USA., Katzelnick LC; Viral Epidemiology and Immunity Unit, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892-3203, USA.
المصدر: Science translational medicine [Sci Transl Med] 2023 Nov 15; Vol. 15 (722), pp. eadi1734. Date of Electronic Publication: 2023 Nov 15.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Washington, DC : American Association for the Advancement of Science
مواضيع طبية MeSH: Dengue*/epidemiology , Dengue Virus* , Zika Virus Infection* , Zika Virus*, Adult ; Child ; Humans ; Antibodies, Viral ; Cross Reactions
مستخلص: Sequential infection with multiple dengue virus (DENV) serotypes is thought to induce enduring protection against dengue disease. However, long-term antibody waning has been observed after repeated DENV infection. Here, we provide evidence that highly immune Nicaraguan children and adults ( n = 4478) experience boosting and waning of antibodies during and after major Zika and dengue epidemics. We develop a susceptible-infected-recovered-susceptible (SIRS-type) model that tracks immunity by titer rather than number of infections to show that boosts in highly immune individuals can contribute to herd immunity, delaying their susceptibility to transmissible infection. In contrast, our model of lifelong immunity in highly immune individuals, as previously assumed, results in complete disease eradication after introduction. Periodic epidemics under this scenario can only be sustained with a constant influx of infected individuals into the population or a high basic reproductive number. We also find that Zika virus infection can boost DENV immunity and produce delays and then surges in dengue epidemics, as observed with real epidemiological data. This work provides insight into factors shaping periodicity in dengue incidence and may inform vaccine efforts to maintain population immunity.
References: Am J Epidemiol. 2009 Jul 1;170(1):120-9. (PMID: 19435864)
Nature. 2017 Jun 15;546(7658):411-415. (PMID: 28538734)
PLoS Negl Trop Dis. 2011 Mar 01;5(3):e975. (PMID: 21390158)
J Infect Dis. 2015 Dec 1;212(11):1743-51. (PMID: 25980035)
Math Biosci. 2013 Dec;246(2):252-9. (PMID: 24427785)
Epidemics. 2017 Sep;20:84-93. (PMID: 28395850)
J Math Biol. 1997 May;35(5):523-44. (PMID: 9145954)
J Virol. 2017 Nov 30;91(24):. (PMID: 28978707)
Proc Natl Acad Sci U S A. 2017 May 30;114(22):E4334-E4343. (PMID: 28442561)
Proc Natl Acad Sci U S A. 2018 Sep 11;115(37):9294-9299. (PMID: 30150394)
Nat Commun. 2019 Apr 10;10(1):1660. (PMID: 30971703)
Clin Infect Dis. 2022 Aug 24;75(1):107-117. (PMID: 34606595)
Lancet Infect Dis. 2020 Mar;20(3):371-380. (PMID: 31870907)
Clin Infect Dis. 2022 Aug 24;75(1):e257-e266. (PMID: 34411230)
Curr Opin Virol. 2020 Aug;43:59-70. (PMID: 32979816)
Proc Natl Acad Sci U S A. 2016 Jan 19;113(3):728-33. (PMID: 26729879)
Front Physiol. 2017 Apr 25;8:233. (PMID: 28487657)
J Infect Dis. 2018 Jul 13;218(4):536-545. (PMID: 29618091)
Arch Virol. 2013 Jul;158(7):1445-59. (PMID: 23471635)
Proc Natl Acad Sci U S A. 2018 Oct 16;115(42):10762-10767. (PMID: 30266790)
Phys Life Rev. 2022 Mar;40:65-92. (PMID: 35219611)
J Math Biol. 2015 Dec;71(6-7):1737-70. (PMID: 25833186)
J Theor Biol. 2011 Nov 21;289:181-96. (PMID: 21907213)
J Infect Dis. 2016 Oct 1;214(7):986-93. (PMID: 26984144)
Proc Natl Acad Sci U S A. 2011 Apr 26;108(17):7259-64. (PMID: 21422281)
Sci Transl Med. 2021 Oct 06;13(614):eabg9478. (PMID: 34613812)
Proc Natl Acad Sci U S A. 2021 Apr 6;118(14):. (PMID: 33811138)
Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):2238-43. (PMID: 18250338)
Front Immunol. 2019 Jun 11;10:1316. (PMID: 31244855)
Proc Natl Acad Sci U S A. 2019 Nov 26;116(48):24268-24274. (PMID: 31712420)
Nat Commun. 2019 Dec 16;10(1):5730. (PMID: 31844054)
Proc Natl Acad Sci U S A. 1999 Jan 19;96(2):790-4. (PMID: 9892712)
Philos Trans R Soc Lond B Biol Sci. 1995 May 30;348(1325):309-20. (PMID: 8577828)
Am J Trop Med Hyg. 2012 Oct;87(4):584-93. (PMID: 23042846)
Nat Commun. 2021 May 11;12(1):2619. (PMID: 33976183)
Trans R Soc Trop Med Hyg. 2000 Sep-Oct;94(5):507. (PMID: 11132376)
Am J Trop Med Hyg. 2016 Jun 1;94(6):1342-7. (PMID: 27022151)
Am J Trop Med Hyg. 2000 Jul-Aug;63(1-2):5-11. (PMID: 11357995)
Proc Natl Acad Sci U S A. 2017 Aug 1;114(31):8384-8389. (PMID: 28716913)
Int J Appl Comput Math. 2022;8(1):45. (PMID: 35132384)
Proc Biol Sci. 2009 Jul 22;276(1667):2541-8. (PMID: 19369266)
J Infect Dis. 2016 Oct 1;214(7):979-81. (PMID: 26984147)
Trans R Soc Trop Med Hyg. 2002 Jul-Aug;96(4):387-97. (PMID: 12497975)
Proc Natl Acad Sci U S A. 2013 May 28;110(22):9072-7. (PMID: 23674683)
Philos Trans R Soc Lond B Biol Sci. 1999 Apr 29;354(1384):757-68. (PMID: 10365401)
J Infect Dis. 2013 Sep;208(6):1026-33. (PMID: 23776195)
Proc Natl Acad Sci U S A. 2005 Oct 18;102(42):15259-64. (PMID: 16217017)
Sci Transl Med. 2016 Mar 16;8(330):330ra36. (PMID: 27089205)
Nature. 2018 May;557(7707):719-723. (PMID: 29795354)
PLoS One. 2010 Aug 23;5(8):e12347. (PMID: 20808806)
PLoS Med. 2019 Jan 22;16(1):e1002726. (PMID: 30668565)
Epidemics. 2022 Jun;39:100583. (PMID: 35665614)
Science. 2017 Nov 17;358(6365):929-932. (PMID: 29097492)
Proc Biol Sci. 2005 Jun 7;272(1568):1171-7. (PMID: 16024379)
Parasit Vectors. 2019 Jul 12;12(1):344. (PMID: 31300061)
Bol Oficina Sanit Panam. 1996 Aug;121(2):102-10. (PMID: 8983243)
N Engl J Med. 2018 Jul 26;379(4):327-340. (PMID: 29897841)
Nat Med. 2021 Aug;27(8):1395-1400. (PMID: 34168334)
Lancet Infect Dis. 2017 Dec;17(12):e420-e428. (PMID: 28757186)
Proc Biol Sci. 2003 Jan 7;270(1510):105-12. (PMID: 12590777)
Proc Natl Acad Sci U S A. 2015 Oct 20;112(42):13069-74. (PMID: 26438851)
Front Immunol. 2014 Jun 11;5:280. (PMID: 24966859)
Math Biosci. 2008 Nov;216(1):114-21. (PMID: 18804482)
PLoS One. 2012;7(11):e49085. (PMID: 23139836)
PLoS Negl Trop Dis. 2016 Feb 05;10(2):e0004398. (PMID: 26848841)
Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14234-9. (PMID: 16966609)
Proc Natl Acad Sci U S A. 2006 Aug 1;103(31):11802-7. (PMID: 16868086)
J Theor Biol. 2020 Jul 21;497:110265. (PMID: 32272134)
Annu Rev Immunol. 2018 Apr 26;36:279-308. (PMID: 29345964)
Clin Infect Dis. 2021 Dec 6;73(11):e4345-e4352. (PMID: 32642771)
PLoS Negl Trop Dis. 2020 Mar 6;14(3):e0008110. (PMID: 32142511)
J Theor Biol. 2007 May 7;246(1):18-27. (PMID: 17270219)
Science. 2020 Aug 28;369(6507):1123-1128. (PMID: 32855339)
معلومات مُعتمدة: HHSN272201000026C United States AI NIAID NIH HHS; R01 AI120997 United States AI NIAID NIH HHS; HHSN272201400006C United States AI NIAID NIH HHS; U01 AI153416 United States AI NIAID NIH HHS; P01 AI106695 United States AI NIAID NIH HHS; U19 AI118610 United States AI NIAID NIH HHS; R01 AI099631 United States AI NIAID NIH HHS
المشرفين على المادة: 0 (Antibodies, Viral)
تواريخ الأحداث: Date Created: 20231115 Date Completed: 20231117 Latest Revision: 20240617
رمز التحديث: 20240617
مُعرف محوري في PubMed: PMC11001200
DOI: 10.1126/scitranslmed.adi1734
PMID: 37967199
قاعدة البيانات: MEDLINE
الوصف
تدمد:1946-6242
DOI:10.1126/scitranslmed.adi1734